First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.
Clinical trial NCT06840782 · RECRUITING
Trial details
- NCT number
- NCT06840782
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-09
- Primary completion
- 2030-02-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.